SpringerLink
Log in

Palliative Chirurgie des Magenkarzinoms

  • Chapter
  • First Online:
Palliative Viszeralchirurgie

  • 1447 Accesses

Zusammenfassung

Das Magenkarzinom ist eine der häufigsten Tumorarten in Deutschland. Bis zu einem Drittel der Patienten hat zum Diagnosezeitpunkt bereits Fernmetatastasen. Diese Patienten sind daher aktuell nicht mehr als kurativ zu behandelnd anzusehen, wenngleich Untersuchungen gezeigt haben, dass sie von einer nicht kurativen Resektion profitieren. Die palliative Resektion sollte von der nicht kurativen unterschieden werden, da sie das Ziel hat, Symptomfreiheit oder zumindest Symptomkontrolle zu erreichen. Dieser Therapieansatz ist insbesondere bei der Tumorstenose, der Tumorblutung, der Peroration oder dem malignen Aszites vordergründig. In diesem Kapitel werden Daten und die Indikationen zur nicht kurativen sowie zur palliativen Resektion dargelegt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
GBP 19.95
Price includes VAT (United Kingdom)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
GBP 59.99
Price includes VAT (United Kingdom)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
GBP 74.99
Price includes VAT (United Kingdom)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Ajani JA, Bentrem DJ, Besh S et al (2013) Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 11:531–546

    Article  CAS  Google Scholar 

  • Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697

    Article  CAS  Google Scholar 

  • Bian SB, Shen WS, ** HQ et al (2016) Palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer: a meta-analysis comparison of gastrojejunostomy with endoscopic stenting. Chin Med J 129:1113–1121

    Article  Google Scholar 

  • Brenner H, Rothenbacher D, Arndt V (2009) Epidemiology of stomach cancer. Methods Mol Biol 472:467–477

    Article  Google Scholar 

  • Canbay E, Mizumoto A, Ichinose M et al (2014) Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan. Ann Surg Oncol 21:1147–1152

    Article  Google Scholar 

  • Chen S, Li YF, Feng XY et al (2012) Significance of palliative gastrectomy for late-stage gastric cancer patients. J Surg Oncol 106:862–871

    Article  Google Scholar 

  • Cheong JH, Hyung WJ, Chen J et al (2004) Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol 94:477–482

    Article  Google Scholar 

  • Cho JH, Lim JY, Choi AR et al (2015) Comparison of surgery plus chemotherapy and palliative chemotherapy alone for advanced gastric cancer with krukenberg tumor. Cancer Res Treat 47:697–705

    Article  CAS  Google Scholar 

  • Desiderio J, Chao J, Melstrom L et al (2017) The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer 79:1–14

    Article  Google Scholar 

  • Dittmar Y, Rauchfuss F, Goetz M et al (2012) Non-curative gastric resection for patients with stage 4 gastric cancer – a single center experience and current review of literature. Langenbecks Arch Surg 397:745–753

    Article  Google Scholar 

  • Elias D, Goere D, Dumont F et al (2014) Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases. Eur J Cancer 50:332–340

    Article  CAS  Google Scholar 

  • Facchiano E, Scaringi S, Kianmanesh R et al (2008) Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer. Eur J Surg Oncol 34:154–158

    Article  CAS  Google Scholar 

  • Facchiano E, Risio D, Kianmanesh R, Msika S (2012) Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims, and results: a systematic review of the literature. Ann Surg Oncol 19:2946–2950

    Article  Google Scholar 

  • Feisthammel J, Fritzsch D, Weis S et al (2012) Endovascular coiling: an important technique in the management of gastrointestinal hemorrhage. Can J Gastroenterol 26:683

    Article  Google Scholar 

  • Fujitani K, Yang HK, Mizusawa J et al (2016) Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol 17:309–318

    Article  CAS  Google Scholar 

  • Hallissey MT, Allum WH, Roginski C, Fielding JW (1988) Palliative surgery for gastric cancer. Cancer 62:440–444

    Article  CAS  Google Scholar 

  • Hartgrink HH, Putter H, Klein Kranenbarg E, Dutch Gastric Cancer Group et al (2002) Value of palliative resection in gastric cancer. Br J Surg 89:1438–1443

    Article  CAS  Google Scholar 

  • Heiss MM, Murawa P, Koralewski P et al (2010) The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial. Int J Cancer 127:2209–2221

    Article  CAS  Google Scholar 

  • Howlader NNA, Krapcho M et al (2019) SEER cancer statistics and review 1975–2007. National Cancer Institute, Bethesda. https://seer.cancer.gov/statfacts/html/stomach.html. Zugegriffen am 03.05.2019

  • Hsu JT, Liao JA, Chuang HC et al (2017) Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer. BMC Palliat Care 16:19

    Article  Google Scholar 

  • Husain A, Bezjak A, Easson A (2010) Malignant ascites symptom cluster in patients referred for paracentesis. Ann Surg Oncol 17:461–469

    Article  Google Scholar 

  • Ito S, Oki E, Nakashima Y et al (2015) Clinical significance of adjuvant surgery following chemotherapy for patients with initially unresectable stage IV gastric cancer. Anticancer Res 35:401–406

    PubMed  Google Scholar 

  • Izuishi K, Haba R, Kushida Y et al (2011) S-1 and the treatment of gastric cancer with peritoneal dissemination. Exp Ther Med 2:985–990

    Article  Google Scholar 

  • Japanese Gastric Cancer Association (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14:113–123

    Article  Google Scholar 

  • Jeurnink SM, Steyerberg EW, van Hooft JE et al (2010) Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 71:490–499

    Article  Google Scholar 

  • Kaminishi M, Yamaguchi H, Shimizu N et al (1997) Stomach-partitioning gastrojejunostomy for unresectable gastric carcinoma. Arch Surg 132:184–187

    Article  CAS  Google Scholar 

  • Kanda T, Yajima K, Kosugi S et al (2012) Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study. Gastric Cancer 15:235–244

    Article  Google Scholar 

  • Keranen I, Kylanpaa L, Udd M et al (2013) Gastric outlet obstruction in gastric cancer: a comparison of three palliative methods. J Surg Oncol 108:537–541

    Article  Google Scholar 

  • Kikuchi S, Tsutsumi O, Kobayashi N et al (1999) Does gastrojejunostomy for unresectable cancer of the gastric antrum offer satisfactory palliation? Hepatogastroenterology 46:584–587

    CAS  PubMed  Google Scholar 

  • Kim HK, Heo DS, Bang YJ, Kim NK (2001) Prognostic factors of Krukenberg’s tumor. Gynecol Oncol 82:105–109

    Article  CAS  Google Scholar 

  • Koizumi W, Narahara H, Hara T et al (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9:215–221

    Article  CAS  Google Scholar 

  • Kokkola A, Louhimo J, Puolakkainen P (2012) Does non-curative gastrectomy improve survival in patients with metastatic gastric cancer? J Surg Oncol 106:193–196

    Article  Google Scholar 

  • Kulig P, Sierzega M, Kowalczyk T et al (2012) Non-curative gastrectomy for metastatic gastric cancer: rationale and long-term outcome in multicenter settings. Eur J Surg Oncol 38:490–496

    Article  CAS  Google Scholar 

  • Lasithiotakis K, Antoniou SA, Antoniou GA et al (2014) Gastrectomy for stage IV gastric cancer. A systematic review and meta-analysis. Anticancer Res 34:2079–2085

    PubMed  Google Scholar 

  • Lindsay JO, Andreyev HJ, Vlavianos P, Westaby D (2004) Self-expanding metal stents for the palliation of malignant gastroduodenal obstruction in patients unsuitable for surgical bypass. Aliment Pharmacol Ther 19:901–905

    Article  CAS  Google Scholar 

  • Medina-Franco H, Contreras-Saldivar A, Ramos-De La Medina A et al (2004) Surgery for stage IV gastric cancer. Am J Surg 187:543–546

    Article  Google Scholar 

  • Miner TJ, Karpeh MS (2004) Gastrectomy for gastric cancer: defining critical elements of patient selection and outcome assessment. Surg Oncol Clin N Am 13:455–466, viii

    Article  Google Scholar 

  • Moehler M, Al-Batran SE, Andus T et al (2011) German S3-guideline „Diagnosis and treatment of esophagogastric cancer“. Z Gastroenterol 49:461–531

    Article  CAS  Google Scholar 

  • Monson JR, Donohue JH, McIlrath DC et al (1991) Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer 68:1863–1868

    Article  CAS  Google Scholar 

  • Nassif T, Prat F, Meduri B et al (2003) Endoscopic palliation of malignant gastric outlet obstruction using self-expandable metallic stents: results of a multicenter study. Endoscopy 35:483–489

    Article  CAS  Google Scholar 

  • No JH, Kim SW, Lim CH et al (2013) Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with good performance status: endoscopic stenting versus surgery. Gastrointest Endosc 78:55–62

    Article  Google Scholar 

  • Park JH, Song HY, Yun SC et al (2016) Gastroduodenal stent placement versus surgical gastrojejunostomy for the palliation of gastric outlet obstructions in patients with unresectable gastric cancer: a propensity score-matched analysis. Eur Radiol 26:2436–2445

    Article  Google Scholar 

  • Randle RW, Swett KR, Swords DS et al (2014) Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites. Ann Surg Oncol 21:1474–1479

    Article  Google Scholar 

  • Rudloff U, Langan RC, Mullinax JE et al (2014) Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol 110:275–284

    Article  Google Scholar 

  • Samarasam I, Chandran BS, Sitaram V et al (2006) Palliative gastrectomy in advanced gastric cancer: is it worthwhile? ANZ J Surg 76:60–63

    Article  Google Scholar 

  • Sarela AI, Miner TJ, Karpeh MS et al (2006) Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg 243:189–195

    Article  Google Scholar 

  • Satoh S, Okabe H, Teramukai S et al (2012) Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer. Gastric Cancer 15:61–69

    Article  CAS  Google Scholar 

  • Sayag-Beaujard AC, Francois Y, Glehen O et al (1999) Intraperitoneal chemo-hyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis. Anticancer Res 19:1375–1382

    CAS  PubMed  Google Scholar 

  • Seshadri RA, Glehen O (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World J Gastroenterol 22:1114–1130

    Article  CAS  Google Scholar 

  • Sougioultzis S, Syrios J, Xynos ID et al (2011) Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis. Eur J Surg Oncol 37:312–318

    Article  CAS  Google Scholar 

  • Takeno A, Takiguchi S, Fujita J et al (2013) Clinical outcome and indications for palliative gastrojejunostomy in unresectable advanced gastric cancer: multi-institutional retrospective analysis. Ann Surg Oncol 20:3527–3533

    Article  Google Scholar 

  • Thomassen I, van Gestel YR, van Ramshorst B et al (2014) Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer 134:622–628

    Article  CAS  Google Scholar 

  • Tokunaga M, Makuuchi R, Miki Y et al (2016) Surgical and survival outcome following truly palliative gastrectomy in patients with incurable gastric cancer. World J Surg 40:1172–1177

    Article  Google Scholar 

  • Vasas P, Wiggins T, Chaudry A et al (2012) Emergency presentation of the gastric cancer; prognosis and implications for service planning. World J Emerg Surg 7:31

    Article  Google Scholar 

  • Wang J, Shi YK, Wu LY et al (2008) Prognostic factors for ovarian metastases from primary gastric cancer. Int J Gynecol Cancer 18:825–832

    Article  CAS  Google Scholar 

  • Wong TC, Wong KT, Chiu PW et al (2011) A comparison of angiographic embolization with surgery after failed endoscopic hemostasis to bleeding peptic ulcers. Gastrointest Endosc 73:900–908

    Article  Google Scholar 

  • World Health Organization (1990) Cancer pain relief and palliative care. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 804:1–75

    Google Scholar 

  • Wu GH, Liu ZH, Wu ZH, Wu ZG (2006) Perioperative artificial nutrition in malnourished gastrointestinal cancer patients. World J Gastroenterol 12:2441–2444

    Article  Google Scholar 

  • Wu X, Li Z, Li Z et al (2015) Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis. J Surg Oncol 111:840–847

    Article  Google Scholar 

  • Xu DZ, Zhan YQ, Sun XW et al (2004) Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 10:2727–2730

    Article  Google Scholar 

  • Yan TD, Black D, Sugarbaker PH et al (2007) A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 14:2702–2713

    Article  Google Scholar 

  • Yang XJ, Huang CQ, Suo T et al (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18:1575–1581

    Article  Google Scholar 

  • Yonemura Y, Fujimura T, Nishimura G et al (1996) Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 119:437–444

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Allgemein-, Viszeral-, Gefäß- und Transplantationschirurgie, Universitätsklinikum, Campus Großhadern und Innenstadt, München, Deutschland

    Florian Bösch & Jens Werner

Authors
  1. Florian Bösch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jens Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Florian Bösch .

Editor information

Editors and Affiliations

  1. Universitätsmedizin Göttingen, Klinik für Allgemein-, Viszeral- und Kinderchirurgie, Göttingen, Germany

    Michael Ghadimi

  2. Klinik für Allgemein, Viszeral- und Gefäßchirurgie, DRK-Kliniken Nordhessen, Kassel, Germany

    Kia Homayounfar

  3. Klinik und Poliklinik für Allgemein-, Universitätsklinikum Bonn Klinik und Poliklinik für Allgemein-, Bonn, Germany

    Jörg C. Kalff

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bösch, F., Werner, J. (2019). Palliative Chirurgie des Magenkarzinoms. In: Ghadimi, M., Homayounfar, K., Kalff, J. (eds) Palliative Viszeralchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57362-4_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57362-4_18

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57361-7

  • Online ISBN: 978-3-662-57362-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation